UNSPSC 51111749: Leurubicin

This classification denotes an anthracycline antibiotic with the molecular formula C33H40N2O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1Z20MGK851, chemically known as (8s,10s)-10-((3-((s)-2-amino-4-methylvaleramido)-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione but generally known as leurubicin, which bears US NIH Compound Identifier 68897.

UNSPSC 51111749 Leurubicin, a Commodity code, nominally addresses a specific pharmaceutical product, but recent state and local solicitations show little activity directly aligned with this code. The most recent opportunities tagged under this code actually procure naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, and medical and first aid supplies for emergency response and pharmacy benefit programs—a broad spectrum of health-related consumables that extends well beyond leurubicin's narrow pharmaceutical scope. The issuing-body mix includes county health departments (Seminole County, Florida), state health agencies and cooperative purchasing alliances (Texas Health and Human Services Commission, Minnesota Multistate Cooperative Purchasing Alliance), and municipal fire departments (City of Tampa). The mismatch between the code's nominal scope and the work being actually solicited suggests either a cataloging error or that this Commodity code functions as a catch-all under a broader family for health-related pharmaceutical and supply procurement.

Geographic activity spans Florida, Texas, and Minnesota, with the Minnesota MMCAP RFP representing a multi-state cooperative purchasing vehicle that includes Oregon. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026; due July 26, 2023) for naloxone and drug deactivation systems with quarterly deliveries to Sanford, Florida; the City of Tampa's IFB 26P00145 (posted March 25, 2026; due March 13, 2026) for medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a sheltered-market set-aside for certified Small Local Business Enterprises; and Minnesota MMCAP's RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) for generic pharmaceuticals and OTC products to be distributed through authorized wholesalers across participating state and local facilities. The Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) represents exploratory procurement for direct-to-manufacturer prescription fulfillment rather than a formal competitive solicitation. The code shows sporadic, geographically dispersed activity with no clear repeat buyer or dominant jurisdiction pattern.